Publications by authors named "Miguel-Angel Perales"

100Publications

The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation.

Blood Rev 2020 Aug 24:100744. Epub 2020 Aug 24.

Department of Medicine, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, USA; Department of Medicine, Weill Cornell Medical College, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2020.100744DOI Listing
August 2020

How I treat adverse effects of CAR-T cell therapy.

ESMO Open 2020 Aug;4(Suppl 4)

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2020-000746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451454PMC
August 2020

Prognostic Factors for Postrelapse Survival after ex Vivo CD34-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.

Biol Blood Marrow Transplant 2020 Nov 23;26(11):2040-2046. Epub 2020 Jul 23.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; The Rockefeller University, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.07.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609585PMC
November 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2020 Oct 5;26(10):1937-1947. Epub 2020 Jul 5.

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, Cornell University, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.06.025DOI Listing
October 2020

Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.

Biol Blood Marrow Transplant 2020 Aug 17;26(8):1459-1468. Epub 2020 May 17.

Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391266PMC
August 2020

Eligibility Criteria for Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

J Natl Compr Canc Netw 2020 05;18(5):635-643

3BMT & Cellular Therapy Program, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2020.7559DOI Listing
May 2020

Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study.

Biol Blood Marrow Transplant 2020 Aug 19;26(8):1482-1491. Epub 2020 Apr 19.

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.03.019DOI Listing
August 2020

CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview.

Bone Marrow Transplant 2020 Aug 18;55(8):1525-1532. Epub 2020 Apr 18.

The Chaim Sheba Medical Center, Tel-Hashomer, Affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-0892-7DOI Listing
August 2020

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic.

Biol Blood Marrow Transplant 2020 07 14;26(7):1239-1246. Epub 2020 Apr 14.

Hematopoietic Cellular Therapy Program, Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194685PMC
July 2020

Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm.

Med Mycol 2020 Nov;58(8):1029-1036

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/mmy/myaa008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657092PMC
November 2020

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.

N Engl J Med 2020 02;382(9):822-834

From the Adult Bone Marrow Transplantation Service (J.U.P., M.M., A.G.C., K.A.M., N.K., D.G.B., M.S.-E., N.C.F., A.A.T., R.J.L., L.Y.S.S., G.L.S., C.C., M.S., I.P., B.G., D.M.P., J.N.B., M.-A.P., S.A.G., M.R.M.B.) and the Infectious Disease Service (Y.T., E.F., L.A.A., R.J.W., E.G.P.), Department of Medicine, the Department of Epidemiology and Biostatistics (S.M.D.), the Department of Immunology, Sloan Kettering Institute (A.L.C.G., E.R.L., A.E.S., J.B.S., C.K.S.-T., M.D.D., M.B.S., G.K.A., Y.S., M.R.M.B.), and the Program for Computational and Systems Biology (J.B.X.), Memorial Sloan Kettering Cancer Center, and the Department of Medicine, Weill Cornell Medical College (J.U.P., Y.T., K.A.M., M.D.D., R.J.L., G.L.S., C.C., M.S., I.P., B.G., D.M.P., J.N.B., M.-A.P., S.A.G., M.R.M.B.) - both in New York; Duchossois Family Institute of the University of Chicago, Chicago (E.R.L., E.G.P.); the Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center (A.D.S., M.V.L., A.B., L.B., N.J.C.), the Division of Infectious Diseases, Department of Medicine, Duke University (J.A.M.), and the Duke Office of Clinical Research, Duke University School of Medicine (K.R.) - all in Durham, NC; the Department of Hematology and Oncology, Internal Medicine III, University Medical Center (D.W., E.H.), the Collaborative Research Center Transregio 221 (D.W., A.G., E.H.), and Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg (A.G.) - all in Regensburg, Germany; the Department of Hematology, Hokkaido University Faculty of Medicine (D.H., Y.H., T.T.), and the Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital (K.H., T.T.) - both in Sapporo, Japan; Research Institute Marqués de Valdecilla-IDIVAL (M.S.-E.) and the Department of Hematology, Hospital Universitario Marqués de Valdecilla-IDIVAL, University of Cantabria (L.Y.S.S.), Santander, and Hospital Universitario Puerta de Hierro, Madrid (A.A.T.) - all in Spain; and the Departments of Genomic Medicine and Stem Cell Transplantation Cellular Therapy, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (R.R.J.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1900623DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534690PMC
February 2020

A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2020 Jun 20;26(6):1195-1202. Epub 2020 Feb 20.

Infectious Disease Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.02.009DOI Listing
June 2020

Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.

Biol Blood Marrow Transplant 2020 Jun 20;26(6):1071-1076. Epub 2020 Feb 20.

Renal Service, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.02.012DOI Listing
June 2020

Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.

J Am Coll Cardiol 2019 12;74(25):3153-3163

Department of Medicine, Weill Cornell Medical College, New York, New York; Cardiology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.10.049DOI Listing
December 2019

Checkpoint inhibitors in AML: are we there yet?

Br J Haematol 2020 01 6;188(1):159-167. Epub 2019 Dec 6.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16358DOI Listing
January 2020

Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy.

Blood Rev 2020 03 14;40:100640. Epub 2019 Nov 14.

Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2019.100640DOI Listing
March 2020

CAR T Cell Toxicity: Current Management and Future Directions.

Hemasphere 2019 Apr 29;3(2):e186. Epub 2019 Mar 29.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HS9.0000000000000186DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746032PMC
April 2019

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives.

Leukemia 2019 12 5;33(12):2767-2778. Epub 2019 Nov 5.

Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0615-5DOI Listing
December 2019

Presalvage International Staging System Stage and Other Important Outcome Associations in CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2020 01 5;26(1):58-65. Epub 2019 Sep 5.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470026PMC
January 2020

Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?

Clin Infect Dis 2020 Apr;70(8):1534-1535

Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciz492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346759PMC
April 2020

Advances in T Cell Depletion - Where Do We Stand?

Adv Cell Gene Ther 2019 Jan 4;2(1). Epub 2018 Dec 4.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acg2.29DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521977PMC
January 2019

Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 06 6;25(6):1136-1141. Epub 2019 Jan 6.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791193001
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.842DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559823PMC
June 2019

ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2019 03 25;25(3):e86-e88. Epub 2018 Dec 25.

Adult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183162
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.757DOI Listing
March 2019

Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes.

Biol Blood Marrow Transplant 2019 04 24;25(4):791-799. Epub 2018 Nov 24.

Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183074
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.11.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784540PMC
April 2019

CAR T cells: The future is already present.

Med Clin (Barc) 2019 04 2;152(7):281-286. Epub 2018 Nov 2.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, Nueva York (NY), Estados Unidos; Weill Cornell Medical College, Nueva York (NY), Estados Unidos. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2018.08.015DOI Listing
April 2019

Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft.

Annu Rev Med 2019 01 25;70:381-393. Epub 2018 Oct 25.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA; email: ,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-120617-041210DOI Listing
January 2019

Severe pembrolizumab-associated neutropenia after CD34 selected allogeneic hematopoietic-cell transplantation for multiple myeloma.

Bone Marrow Transplant 2018 08 7;53(8):1065-1068. Epub 2018 Mar 7.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0142-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6984164PMC
August 2018

Reprint of: Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.

Biol Blood Marrow Transplant 2018 03;24(3S):S15-S19

Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.789DOI Listing
March 2018

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

Biol Blood Marrow Transplant 2018 04 27;24(4):871-876. Epub 2017 Dec 27.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673673PMC
April 2018

Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR.

Biol Blood Marrow Transplant 2018 01 13;24(1):27-31. Epub 2017 Oct 13.

Center for Cell Engineering and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901894PMC
January 2018